San Francisco, California
Who You Are
The Associate Medical Director, Rare Disease will participate in the development and execution of clinical initiatives in the achondroplasia program. He/she will provide expert support to clinical development activities, including the design, implementation, monitoring, analysis, and reporting of clinical studies. The successful candidate will have demonstrated an ability to work independently as well as the flexibility to function successfully in a multidisciplinary team environment.
- Assisting in the overall management, planning, evaluation and documentation of projects and studies.
- Participation in new and on-going development activities including:
- Development and writing clinical plans and protocols ensuring scientific integrity.
- Participate/conduct investigator meetings and site initiation visits with clinical trial investigators.
- Monitoring and review of clinical data.
- Analysis, interpretation and presentation of study data.
- Authoring of clinical study reports, IBs, ICFs, training documents, and other clinical and regulatory documents
- Participation in the preparation of abstracts, posters and presentations for scientific meetings, congresses, and interactions with Key Opinion Leaders.
- Close collaboration with drug safety, regulatory affairs, medical affairs and clinical trial operations.
Education, Experience & Skills Requirements:
- M.D. degree
- Medical experience in Pediatrics or rare diseases desirable.
- At least 2 years of relevant drug development experience, either within industry or as a clinical investigator/physician scientist in academia, or equivalent experience.
- Ability to develop and maintain excellent working relationships with both internal colleagues and external contacts, including key thought leaders, and investigators.
- Demonstrated ability to be a fast learner.
- Ability to communicate and work independently.
- Ability to think critically, troubleshooting and problem-solving skills.
- Excellent written and verbal skills and strong interpersonal skills required
- Comfortable in a fast-paced small company environment, able to adjust workload based upon changing priorities.
- May travel up to 25%.
What We Offer
Patient Days, where we are fortunate enough to learn more about the lives we are looking to impact and a real exchange of ideas as to how we can improve our efforts.
A culture inspired by our values: put patients first; think independently, be radically transparent; every minute counts; and let science speak.
Learning and development training to help employees be the best version of themselves.
Collaborative business environment.
Excellent compensation package (Base, Performance Bonus, Stock, RSU programs).
Excellent benefits package.
With office locations in San Francisco, Boston, New York and Raleigh, there are ample cross-collaboration opportunities with other BridgeBio Pharma programs.
Fast-paced, data-driven, work environment with world-class R&D minds and capabilities.
Work with the most productive groups of R&D operators in the industry.
Partnerships with leading institutions.
A platform for meaningful scientific contributions to shine.
Commitment to Diversity & Inclusion – with initiatives like Women at Bridge, we are committed to fostering an inclusive environment where every person feels respected for who they are, empowered to contribute, inspired to lead and supported in their efforts to do so.
With singular focus, QED is devoted to the development of our investigational candidate, infigratinib. A first-in-class, selective, tyrosine kinase inhibitor, infigratinib has promising early clinical data in patients with previously treated, FGFR-driven cholangiocarcinoma and metastatic urothelial carcinoma, as well as preclinical studies in achondroplasia. Future studies will investigate infigratinib for additional FGFR-driven tumor types and rare disorders.